The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
I am an immunologist studying the interaction between cancer and the immune system. I am involved in the development and characterization of immunotherapies for cancer.
The Australia Fellowship will enable Prof Good to pursue the development of vaccines for two major pathogens – malaria and group A streptococcus (GAS). Both research programs are entering exciting phases as we move into Phase I clinical trials. At the same time, the Fellowship will enable us to explore the development of the next generation vaccine candidates for these diseases. Malaria is responsible for approximately 1 million deaths per year, mainly of children under 5 years of age, while dis ....The Australia Fellowship will enable Prof Good to pursue the development of vaccines for two major pathogens – malaria and group A streptococcus (GAS). Both research programs are entering exciting phases as we move into Phase I clinical trials. At the same time, the Fellowship will enable us to explore the development of the next generation vaccine candidates for these diseases. Malaria is responsible for approximately 1 million deaths per year, mainly of children under 5 years of age, while diseases caused by group A streptococcus (such as rheumatic heart disease [RHD] and RHD-related stroke) are responsible for at least 500,000 deaths per year. Australia’s Indigenous population suffer the highest documented rate of RHD in the world. We have strong international support and collaboration for these vaccine research programs and have approached the US FDA for a license to conduct the trial for a GAS vaccine and will soon approach them for a licence to undertake the malaria vaccine trial.Read moreRead less
I am a structural biologist investigating the structure and function of malaria surface proteins as vaccine candidates, regulators of cytokine signalling and pharmacologically active toxins.
I am a molecular parasitologist exploring parasitism in blood-feeding human helminths, with a particular focus on the molecular biology of parasite feeding and immune evasion. I am utilizing this information to develop anti-helminth recombinant vaccines a
I am a cellular immunologist with expertise in antigen processing-presentation, CTL determinant selection and immunodominance, T cell differentiation and, cancer immunotherapeutic trials and cancer vaccine development.